Work

Secukinumab, a novel anti-IL-17A antibody, exhibits low immunogenicity in clinical trials and human in vitro assays

Year: 2016

Type: article

Source: Journal of Dermatological Science

DOI: 10.1016/j.jdermsci.2016.08.367

Authors: Frank Kolbinger, Andrew Blauvelt, April Armstrong, Todd Fox, Jiaqing Huang, Eric Liang, Annette Karle, Sebastian Spindeldreher, Gerard Bruin, Kristian Reich

Institutions: Novartis Institutes for BioMedical Research, Oregon Medical Research Center, University of Colorado Anschutz, University of Colorado Denver, Novartis (Switzerland), Dermatologikum Hamburg, University of Göttingen

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523913862

FWCI: 0.169

Cites:

Cited by: 3

Related to: 10